Connect with us
The European Union plans to become an important point for clinical trials. The work plan is structured according to the ten ACT EU priority actions and...
The Swiss pharmaceutical company plans to lay off 8,000 workers worldwide, equivalent to 7.7% of the total workforce. The Novartis job cuts are part of the...
Bioasis Technologies Inc. has recently announced partnerships for its xB3 pharmaceutical platform with Janssen Biotech and Nueramedy, along with the acquisition of Cresence AS' Epidermal Growth...
During the project, two demonstration units will be built for the production of microalgae from these agricultural effluents, one in the Algarve and the second in...
At its latest meeting, held July 28th, REvalMed group has agreed to start work on the Therapeutic Positioning Reports (TPRs) for vutrisiran, voclosporin, tirzepatide, fosdenopterin, relatlimab...
The response to Covid-19 by governments and the medical community demonstrated the possibilities of rapid testing and vaccine development. Now one company, Alercell, is looking to...
As vaccine sales for Novavax, Moderna, and BioNTech shift in line with a changing Covid-19 situation, the results are being felt in the stock markets. Here...
The new transaction is aimed at equipping Lipogems with the necessary resources to accelerate the development of therapies for priority clinical indications, primarily knee osteoarthritis, for...
Grifols and Pharma Mar reduced profits, while Reig Jofre, Faes Farma, Rovi and Almirall increased their profits between January and June. This last company has exceeded...
Mediquo has recently closed a financing round and plans to make to leap to Mexico. Most of the company's existing partners participated in this round, in...
 |
|
 |  |
 |
|